Elevance raises 2026 adjusted EPS guidance to at least $29 while targeting at least 12% growth in 2027

Elevance Health (ELV) Q3 2026 earnings call highlights: raised adjusted EPS guidance to $29+, Medicaid/MA/ACA drivers, and 2027 outlook—read now.